View More Recent Stories

Oct 10, 2022 08:30AM Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Sep 12, 2022 08:30AM Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium
Aug 31, 2022 08:30AM Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 15, 2022 08:30AM Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
Jul 21, 2022 08:33AM Anixa Biosciences (ANIX) Granted Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
Jul 21, 2022 08:30AM Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
Jun 21, 2022 08:31AM Anixa Biosciences (ANIX) Announces Publication Highlighting Ovarian Cancer Vaccine Technology
Jun 21, 2022 08:30AM Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
May 5, 2022 08:30AM Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Apr 28, 2022 08:30AM Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 6, 2022 08:30AM Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
Mar 30, 2022 12:45PM Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
Mar 27, 2019 07:00AM Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy
View More Recent Stories